About simp7342

Dr Erik Miljan has over 10 years experience in the Stem Cell Biotech sector, from intellectual property (IP) portfolio management through product development to regulatory approval. Initiated, implemented and delivered the operational and management strategy leading to the first ever stem cell based product approved for clinical trial in the UK in addition to delivering non-therapeutic stem cell products to market. He has experience in International settings across both academia and industry in the US, Japan, Australia and the European Union.